New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated ...

Bengaluru: Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide, including in India.

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

An expert discusses how radiopharmaceuticals such as radium-223 offer a valuable different mechanism of action in treating advanced prostate cancer, requiring careful patient selection, safety ...

An expert discusses how CT scans and bone scans remain the standard imaging approach for most patients with metastatic castration-resistant prostate cancer (mCRPC), whereas prostate-specific membrane ...

The tissue damage and anatomical distortion caused by primary prostate cancer treatment are major challenges for surgeons performing salvage surgery.

Men with non-metastatic forms are likely to live 'for many years' after diagnosis when active surveillance and other NCCN ...

ArteraAI Prostate analyzes digital pathology images of a prostate cancer biopsy slide to help clinicians predict long-term outcomes.

Real-world data suggest that Erleada may offer an advantage over other treatment options for patients with metastatic ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

The group argues the former president’s doctor erred by either failing to administer a cancer test while Biden was in office ...